Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Es la segunda noticia que leo sobre los mismos términos.
However, investors need to tame their enthusiasm as Threshold Pharmaceuticals is years away from an FDA approval along with the commercialization of TH-302. Threshold Pharmaceuticals also apparently has 11 clinical trials ongoing – meaning investors will need to watch the company’s cash burn and should probably expect some dilution next year as it will probably need to shore up its finances with a stock offering.
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Es injustificado, después de ASCO entendí que había demasiada expectación y una subida bestial, pero ahora mismo, con unos resultados buenos en 2 tipos diferentes de cáncer publicados durante este mes, no se, espero que sea miedo irracional de los homegamers, porque sino............... no quiero ni pensarlo. argggggg